R&D Update/Patent Box- Cancelled

Alan will provide an overview of recent R&D tax developments and Patent Box:

  • Patent box –provides an effective tax rate of 17% for income derived from the exploitation of qualifying patents, for investment in sectors such as: medical, biotechnology, agriculture and low carbon emissions
  • R&D tax - Clinical Trials Determination 
  • R&D tax - Software specific guidance 
  • R&D tax - Dual Agency Administration Model – Findings

Presented by: Alan Garcia

Managing Director at boutique firm Thread Incentives (and previously Senior Partner and Asia Pacific Regional R&D leader with a global big 4 firm). Alan has 24 years’ expertise across jurisdictions and sectors leading R&D claims and driving funding applications: R&D scoping and technical drafting, tax governance, R&D due diligence, claim defence, strategy and R&D litigation support. Focus areas include sourcing funds for small and large companies and supporting companies with compliance, substantiation and the changing rules around R&D and Patent Box incentives.

15/05/2022 - 15/05/2022
Online, Australia

Login with your email address